Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

scientific article published on 01 February 2003

Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/JNCI/95.4.332-B
P698PubMed publication ID12591993

P50authorRoberto Mario ScarpaQ37828663
P2093author name stringAlfredo Berruti
Alberto Angeli
Marcello Tucci
Carlo Terrone
Luigi Dogliotti
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectmetastatic prostate carcinomaQ55779807
placebo-controlled trialQ108853737
zoledronic acidQ218507
placeboQ269829
P304page(s)332-3; author reply 333-4
P577publication date2003-02-01
P1433published inJournal of the National Cancer InstituteQ400279
P1476titleRe: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma
P478volume95

Search more.